Skip to content
Search

Latest Stories

NI pharmacies to get £300 SSP cost reimbursement

Northern Ireland community pharmacies will receive a flat fee of £300 as the reimbursement towards costs associated with the introduction of serious shortage protocols (SSPs).

The Health and Social Care Board (HSCB) told community pharmacy owners in a letter on January 30 that they would be reimbursed for any "costs associated with development of processes, training within the pharmacy and the implementation of any SSPs that would be delivered in the remainder of the 2019/20 financial year."


In addition to the £300 payment, all pharmacists will also receive a fee based on dispensing volumes over a 12-month period.

Tier 1 (0 - 48,000 items) £128.12

Tier 2 (48,000 - 70,000 items) £256.24

Tier 3 (70,000 - 100,000 items) £384.36

Tier 4 (100,000 + items) £512.48

The funding will be included in the January 2020 payment to the pharmacies.

So far, no SSPs have been issued in Northern Ireland, while England issued the first three SSPs in October 2019.

The only SSP currently active in the UK is for Haloperidol 500 microgram capsules and it is due to expire on March 23.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less